Ryuichiro Sawada Selected Research

Esophageal Squamous Cell Carcinoma

5/2024	The number of resected lymph nodes from the upper mediastinal area predicts long-term outcomes of esophageal squamous cell carcinoma after minimally invasive esophagectomy.
2/2024	ASO Visual Abstract: Impact of Tumor Size on Survival Outcome in Esophageal Squamous Cell Carcinoma After Esophagectomy Following Neoadjuvant Chemotherapy.
1/2024	Protocol for a phase II study to evaluate the efficacy and safety of nivolumab as a postoperative adjuvant therapy for patients with esophageal cancer treated with preoperative docetaxel, cisplatin plus 5-fluorouracil treatment (PENTAGON trial).
12/2023	Impact of Tumor Size on Survival Outcome in Esophageal Squamous Cell Carcinoma After Esophagectomy Following Neoadjuvant Chemotherapy.
12/2022	Short- and long-term outcomes of thoracoscopic esophagectomy in the prone position for esophageal squamous cell carcinoma in patients with obstructive ventilatory disorder: a propensity score-matched study.
10/2022	ASO Author Reflections: Decrease of Albumin and Derived Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy Reflect the Worse Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
10/2022	ASO Visual Abstract: Albumin and Derived Neutrophil-To-Lymphocyte Ratio is a Novel Prognostic Factor for Patients with Esophageal Squamous Cell Carcinoma.
10/2022	Albumin and Derived Neutrophil-to-Lymphocyte Ratio is a Novel Prognostic Factor for Patients with Esophageal Squamous Cell Carcinoma.
5/2022	Impact of the Platelet-to-Lymphocyte Ratio as a Biomarker for Esophageal Squamous Cell Carcinoma.
4/2022	Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell Carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryuichiro Sawada Research Topics

Disease

13	Esophageal Squamous Cell Carcinoma 05/2024 - 08/2019
13	Neoplasms (Cancer) 02/2024 - 12/2018
11	Rectal Neoplasms (Rectal Cancer) 01/2024 - 10/2021
5	Stomach Neoplasms (Stomach Cancer) 01/2024 - 01/2022
5	Adenocarcinoma 12/2023 - 03/2022
4	Carcinoma (Carcinomatosis) 07/2023 - 09/2019
3	Esophageal Neoplasms (Esophageal Cancer) 01/2024 - 06/2022
3	Carcinogenesis 12/2023 - 09/2019
2	Inflammation (Inflammations) 01/2024 - 10/2022
2	Sarcopenia 12/2023 - 06/2022
2	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 01/2023
2	Lymphatic Metastasis 12/2023 - 01/2023
2	Neoplasm Metastasis (Metastasis) 12/2022 - 12/2022
2	Cholangiocarcinoma 01/2021 - 08/2018
1	Frailty 01/2024
1	Tooth Loss 01/2024
1	Body Weight (Weight, Body) 12/2023
1	Paralysis (Palsy) 12/2023
1	Anastomotic Leak 12/2023
1	Obesity 04/2023
1	Pneumonia (Pneumonitis) 04/2023
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2022
1	Cholecystitis 09/2019
1	Pancreaticobiliary Maljunction 09/2019
1	Gallbladder Neoplasms (Gallbladder Cancer) 09/2019
1	Klatskin Tumor 08/2018

Drug/Important Bio-Agent (IBA)

7	AlbuminsIBA 01/2024 - 04/2022
2	Fluorouracil (Carac)FDA LinkGeneric 01/2024 - 08/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 08/2019
2	CateninsIBA 12/2023 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 05/2022
2	Interleukin-33IBA 09/2019 - 08/2018
1	Docetaxel (Taxotere)FDA Link 01/2024
1	Serum AlbuminIBA 01/2024
1	NivolumabIBA 01/2024
1	tetraethylpyrazine (TEP)IBA 04/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2022
1	CreatinineIBA 06/2022
1	C-Reactive ProteinIBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	Calcium-Binding ProteinsIBA 01/2021
1	Messenger RNA (mRNA)IBA 09/2019
1	phytobacteriomycin (PBM)IBA 09/2019
1	Interleukin-6 (Interleukin 6)IBA 09/2019
1	InterleukinsIBA 08/2018

Therapy/Procedure

16	Neoadjuvant Therapy 02/2024 - 08/2019
14	Esophagectomy 05/2024 - 12/2018
7	Gastrectomy 01/2024 - 01/2022
4	Lymph Node Excision (Lymph Node Dissection) 12/2023 - 11/2021
3	Therapeutics 01/2024 - 10/2021
3	Adjuvant Chemotherapy 01/2024 - 02/2022
2	Drug Therapy (Chemotherapy) 12/2023 - 12/2022
2	Operative Time 04/2023 - 01/2023
1	Enteral Nutrition (Feeding, Tube) 12/2023
1	Jejunostomy 12/2023
1	Hepatectomy 12/2022
1	Stents 11/2022
1	Proctectomy 05/2022
1	Combined Modality Therapy 02/2022
1	Chemoradiotherapy 10/2021